Neogen Announces CFO Transition

LANSING, Mich., Sept. 27, 2022 /PRNewswire/ -- Neogen Corporation announced that Steve Quinlan, the company's chief financial officer, has announced his intent to retire effective May 31, 2023, at the conclusion of the company's fiscal year. Quinlan has served as Neogen's CFO since 2011, leading the company through more than 30 acquisitions, including the company's recent acquisition of 3M's Food Safety business, and driving revenue growth from $172.6 million in 2011 to upwards of $527 million in 2022.

"Steve has played a critical role in Neogen's growth over the past 11 years and has been an exceptional leader and benefit to our team," said John Adent, Neogen's president and CEO. "Steve and I worked together to plan his succession, and he will be staying on through the remainder of the fiscal year to ensure a smooth transition. I appreciate all of Steve's contributions to the business and wish him and his family all the best in his retirement."

Neogen also announced the naming of David Naemura as chief financial officer, effective Jan. 2, 2023. During the five-month overlapping period, he and Quinlan will work together to ensure a smooth transition of responsibilities. He brings extensive experience as an operationally oriented CFO in public company environments and has significant experience in building high-performance teams. Naemura was previously the chief financial officer of Vontier Corporation, where he played an instrumental role in the company's separation and launch as an independent public company. Prior to his time at Vontier, Naemura was the chief financial officer of Gates Industrial Corporation and also served as a group chief financial officer for Danaher Corporation.

"I am very pleased to welcome Dave to the Neogen team. His extensive experience working for public companies makes him not only a great fit for Neogen but also an important asset to help us deliver on our mission and drive the company far into the future as we enter a new era in food security," Adent said.